HomeCompareATY vs MRK

ATY vs MRK: Dividend Comparison 2026

ATY yields 125.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATY wins by $10.25M in total portfolio value
10 years
ATY
ATY
● Live price
125.00%
Share price
$1.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.30M
Annual income
$4,003,529.03
Full ATY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ATY vs MRK

📍 ATY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATY
Annual income on $10K today (after 15% tax)
$10,625.00/yr
After 10yr DRIP, annual income (after tax)
$3,402,999.68/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ATY beats the other by $3,394,671.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATY + MRK for your $10,000?

ATY: 50%MRK: 50%
100% MRK50/50100% ATY
Portfolio after 10yr
$5.18M
Annual income
$2,006,663.59/yr
Blended yield
38.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ATY
Analyst Ratings
2
Buy
1
Hold
Consensus: Buy
Price Target
$2.50
+56.2% upside vs current
Range: $2.50 — $2.50
Altman Z
4.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATY buys
0
MRK buys
0
No recent congressional trades found for ATY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATYMRK
Forward yield125.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$10.30M$56.8K
Annual income after 10y$4,003,529.03$9,798.13
Total dividends collected$9.40M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$2.50$128.54

Year-by-year: ATY vs MRK ($10,000, DRIP)

YearATY PortfolioATY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$23,200$12,500.00$11,206$366.19+$12.0KATY
2$51,927$27,102.80$12,650$502.35+$39.3KATY
3$112,255$56,693.60$14,407$694.19+$97.8KATY
4$234,655$114,542.19$16,585$967.82+$218.1KATY
5$474,853$223,771.79$19,342$1,363.89+$455.5KATY
6$931,297$423,204.53$22,913$1,947.19+$908.4KATY
7$1,772,191$775,703.35$27,662$2,823.89+$1.74MATY
8$3,275,784$1,379,539.67$34,159$4,173.35+$3.24MATY
9$5,888,260$2,383,170.48$43,337$6,308.80+$5.84MATY
10$10,303,967$4,003,529.03$56,776$9,798.13+$10.25MATY

ATY vs MRK: Complete Analysis 2026

ATYStock

AcuityAds Holdings Inc., a technology company, provides digital media solutions. The company offers a programmatic marketing platform that enables advertisers to connect with their audiences across online display, video, social, and mobile campaigns. Its platform also allows advertisers to manage their purchasing of online display advertising in real-time using programmatic ad buying. The company serves Fortune 500 enterprises and small to mid-sized businesses in the United States, Canada, Europe, the Middle East, and Africa. AcuityAds Holdings Inc. is headquartered in Toronto, Canada.

Full ATY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ATY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATY vs SCHDATY vs JEPIATY vs OATY vs KOATY vs MAINATY vs JNJATY vs ABBVATY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.